Biotron Share Price Competition Jan 1 2022, page-194

Good to see that you have recovered Moosey. Nearly all the people I know who have caught COVID have enjoyed the experience - though a few did not seem to get a very bad does at all.

I'll throw in some comments here - they won't be liked but they are here for perspective. They are my opinions only and I get it wrong 50% of the time Please don't hurt me Hopefully, this could develop some meaningful conversation.

1) I still maintain that BIT should concentrate purely on HIV/HepC research and push hard to commercialise products in that area.
2) I believe that BIT will not be entirely successful in the COVID area - every biotech on the planet is in this field (from antivirals to food supplements) and all are saying that they are on the road to a cure. No every company will get it right. If holders are pinning their hopes on BIT getting a cure for COVID then I think those hopes are somewhat misplaced.
3) after 10 years that I have either owned BIT shares or kept an interest in the company, I cannot understand why BITS compounds have not been taken up by the big players. On paper, this should have happened if those compounds were as good as BIT's trial results indicated.
4) If BIT fails to nail some big commercial deal in the next two years, then I think BIT is going nowhere. I sincerely hope that something great happens in 2022 - that includes some commercial deal or partnership with HIV/HepC - where I think the money is for BIT.
5) It is concerning that BIT is still in the research phase a decade after they had a great product.

I am an eternal optimist with BIT. I liked what they were doing when I was attracted to the company 10 years ago. I still remain optimistic BUT the next two years will determine BIT's future.

OK - you can give me a good whacking now.